Published in Arch Pathol Lab Med on November 01, 2002
Return of individual research results from genome-wide association studies: experience of the Electronic Medical Records and Genomics (eMERGE) Network. Genet Med (2012) 3.29
Left sided inferior vena cava duplication and venous thromboembolism: case report and review of literature. J Hematol Oncol (2008) 1.32
CLIA-tested genetic variants on commercial SNP arrays: potential for incidental findings in genome-wide association studies. Genet Med (2010) 1.21
Health-related direct-to-consumer genetic tests: a public health assessment and analysis of practices related to Internet-based tests for risk of thrombosis. Public Health Genomics (2008) 1.08
Hereditary thrombophilia. Thromb J (2006) 1.08
Epidemiology of venous thromboembolism. Nat Rev Cardiol (2015) 1.07
Hypercoagulable states: an algorithmic approach to laboratory testing and update on monitoring of direct oral anticoagulants. Blood Res (2014) 0.87
Usefulness of factor V Leiden mutation testing in clinical practice. Eur J Hum Genet (2010) 0.82
Motivating factors for physician ordering of factor V Leiden genetic tests. Arch Intern Med (2009) 0.81
Hereditary thrombophilic risk factors for recurrent pregnancy loss. J Community Genet (2010) 0.79
Use of Factor V Leiden genetic testing in practice and impact on management. Genet Med (2009) 0.79
Testing for hereditary thrombophilia: a retrospective analysis of testing referred to a national laboratory. BMC Clin Pathol (2008) 0.78
Prevalence of thrombophilia in asymptomatic individuals with a family history of thrombosis. Hippokratia (2013) 0.75
Evaluation of chromosomal abnormalities and common trombophilic mutations in cases with recurrent miscarriage. Afr Health Sci (2014) 0.75
Electronic health record interventions at the point of care improve documentation of care processes and decrease orders for genetic tests commonly ordered by nongeneticists. Genet Med (2016) 0.75
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 16.17
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest (2004) 11.84
Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med (2003) 8.65
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial. Lancet (2009) 6.83
Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2014) 6.55
Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2012) 6.24
Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2013) 6.13
Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition). Reg Anesth Pain Med (2010) 4.77
Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study. J Am Coll Cardiol (2005) 4.39
Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med (2002) 3.96
Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med (2003) 3.85
Detectable clonal mosaicism from birth to old age and its relationship to cancer. Nat Genet (2012) 3.68
Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost (2007) 3.67
The Gene, Environment Association Studies consortium (GENEVA): maximizing the knowledge obtained from GWAS by collaboration across studies of multiple conditions. Genet Epidemiol (2010) 3.48
Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 3.36
D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study. Ann Intern Med (2015) 2.63
Assessment of hemostatic risk factors in predicting arterial thrombotic events. Arterioscler Thromb Vasc Biol (2005) 2.45
Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism. Am J Hematol (2007) 2.06
Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin Cancer Res (2009) 2.04
Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation. Mayo Clin Proc (2008) 1.97
Prevention of venous thromboembolism. Chest (2005) 1.76
Mayo Genome Consortia: a genotype-phenotype resource for genome-wide association studies with an application to the analysis of circulating bilirubin levels. Mayo Clin Proc (2011) 1.62
Methodology for isolation, identification and characterization of microvesicles in peripheral blood. J Immunol Methods (2011) 1.58
Surveillance for deep vein thrombosis and pulmonary embolism: recommendations from a national workshop. Am J Prev Med (2010) 1.55
Evaluation of a screening tool for bleeding disorders in a US multisite cohort of women with menorrhagia. Am J Obstet Gynecol (2011) 1.47
Characterization of blood borne microparticles as markers of premature coronary calcification in newly menopausal women. Am J Physiol Heart Circ Physiol (2008) 1.44
The potential role of fondaparinux as venous thromboembolism prophylaxis after total hip or knee replacement or hip fracture surgery. Arch Intern Med (2002) 1.44
The use of recombinant activated factor VII in three patients with central nervous system hemorrhages associated with factor VII deficiency. Transfusion (2004) 1.43
Population pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct factor Xa inhibitor--in patients undergoing major orthopaedic surgery. Clin Pharmacokinet (2008) 1.39
Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events? Arthritis Rheum (2012) 1.34
Phenotype harmonization and cross-study collaboration in GWAS consortia: the GENEVA experience. Genet Epidemiol (2011) 1.29
Identifying in-hospital venous thromboembolism (VTE): a comparison of claims-based approaches with the Rochester Epidemiology Project VTE cohort. Med Care (2008) 1.24
Incidence and cost burden of post-thrombotic syndrome. J Thromb Thrombolysis (2009) 1.18
Alterations in platelet function and cell-derived microvesicles in recently menopausal women: relationship to metabolic syndrome and atherogenic risk. J Cardiovasc Transl Res (2011) 1.11
Rituximab for refractory and or relapsing thrombotic thrombocytopenic purpura related to immune-mediated severe ADAMTS13-deficiency: a report of four cases and a systematic review of the literature. Eur J Haematol (2009) 1.09
Warfarin sensitivity genotyping: a review of the literature and summary of patient experience. Mayo Clin Proc (2009) 1.07
Fondaparinux, the first selective factor Xa inhibitor. Curr Opin Hematol (2003) 1.06
Quantification of hypercoagulable state after blunt trauma: microparticle and thrombin generation are increased relative to injury severity, while standard markers are not. Surgery (2012) 0.99
Venous thrombosis in the elderly: more questions than answers. Blood (2007) 0.98
Cancer-associated microangiopathic hemolytic anemia with thrombocytopenia: an important diagnostic consideration. Eur J Haematol (2010) 0.97
Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid. Br J Haematol (2009) 0.97
Is progestin an independent risk factor for incident venous thromboembolism? A population-based case-control study. Thromb Res (2010) 0.96
A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT). Thromb Haemost (2009) 0.96
Risk factors and underlying mechanisms for venous stasis syndrome: a population-based case-control study. Vasc Med (2009) 0.96
Outcomes after withholding anticoagulation from patients with suspected acute pulmonary embolism and negative computed tomographic findings: a cohort study. Mayo Clin Proc (2002) 0.94
The thrombospondin-1 N700S polymorphism is associated with early myocardial infarction without altering von Willebrand factor multimer size. Blood (2006) 0.93
Genetic polymorphisms associated with carotid artery intima-media thickness and coronary artery calcification in women of the Kronos Early Estrogen Prevention Study. Physiol Genomics (2012) 0.93
Plasma von Willebrand factor multimer quantitative analysis by in-gel immunostaining and infrared fluorescent imaging. Thromb Res (2010) 0.92
Estrogen, inflammation, and platelet phenotype. Gend Med (2008) 0.92
Risk factors for venous thromboembolism in nursing home residents. Mayo Clin Proc (2008) 0.92
Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study). Br J Haematol (2012) 0.91
Identification of a novel percent mammographic density locus at 12q24. Hum Mol Genet (2012) 0.88
Coagulation activation and long-term outcome in acute coronary syndromes. Blood (2003) 0.88
Stroke prevention in atrial fibrillation in older adults: existing knowledge gaps and areas for innovation: a summary of an American Federation for Aging research seminar. J Am Geriatr Soc (2013) 0.88
Inherited and secondary thrombophilia. Circulation (2014) 0.87
Rivaroxaban for thromboprophylaxis after orthopaedic surgery: pooled analysis of two studies. Thromb Haemost (2007) 0.87
Peri-procedural anticoagulation management of mechanical prosthetic heart valve patients. Thromb Res (2009) 0.87
The thrombogenicity of C1 esterase inhibitor (human): review of the evidence. Allergy Asthma Proc (2015) 0.86
Prevention and treatment of venous thromboembolism in pregnancy in patients with hereditary antithrombin deficiency. Int J Womens Health (2013) 0.86
Venous thromboembolism hospitalizations among American Indians and Alaska Natives. Thromb Res (2002) 0.86
Periprocedural anticoagulation management of patients with venous thromboembolism. Arterioscler Thromb Vasc Biol (2010) 0.85
Association of the PDYN gene with alcohol dependence and the propensity to drink in negative emotional states. Int J Neuropsychopharmacol (2012) 0.85
Thromboembolism in adults with acute lymphoblastic leukemia during induction with L-asparaginase-containing multi-agent regimens: incidence, risk factors, and possible role of antithrombin. Leuk Lymphoma (2004) 0.84
Replication of genome wide association studies of alcohol dependence: support for association with variation in ADH1C. PLoS One (2013) 0.84
Obstetric complications in patients with hereditary thrombophilia identified using the LCx microparticle enzyme immunoassay: a controlled study of 5,000 patients. Am J Clin Pathol (2007) 0.83
Clinical importance of positive test results for lupus anticoagulant and anticardiolipin antibodies. Mayo Clin Proc (2004) 0.83
Use of recombinant human antithrombin in patients with congenital antithrombin deficiency undergoing surgical procedures. Transfusion (2003) 0.82
Recombinant nematode anticoagulant protein c2, a novel inhibitor of tissue factor-factor VIIa activity, abrogates endotoxin-induced coagulation in chimpanzees. Thromb Haemost (2002) 0.82
Association of GATA4 sequence variation with alcohol dependence. Addict Biol (2012) 0.82
Hypercoagulability in Kidney Transplant Recipients. Transplantation (2016) 0.82
The association of active cancer with venous thromboembolism location: a population-based study. Mayo Clin Proc (2011) 0.81
F9 Malmö, factor IX and deep vein thrombosis. Haematologica (2009) 0.81
Thrombin generation and procoagulant microparticle profiles after acute trauma: A prospective cohort study. J Trauma Acute Care Surg (2015) 0.81
Venous thromboembolism in nursing home residents: role of selected risk factors. J Am Geriatr Soc (2012) 0.80
New pentasaccharides for the prophylaxis of venous thromboembolism: clinical studies. Chest (2003) 0.80
Thrombophilia and new anticoagulant drugs. Hematology Am Soc Hematol Educ Program (2004) 0.80
Superiority of fondaparinux over enoxaparin in preventing venous thromboembolism in major orthopedic surgery using different efficacy end points. Chest (2004) 0.80
Incidence and predictors of venous thromboembolism after debulking surgery for epithelial ovarian cancer. Int J Gynecol Cancer (2013) 0.79
Differential effects of oral and transdermal menopausal hormone therapy on prostacyclin and thromboxane in platelets. Physiol Rep (2014) 0.79
Timing of postpartum enoxaparin administration and severe postpartum hemorrhage. Blood Coagul Fibrinolysis (2008) 0.78
The use of antithrombotic therapies in the prevention and treatment of arterial and venous thrombosis: a survey of current knowledge and practice supporting the need for clinical education. Crit Pathw Cardiol (2010) 0.78
Polymorphisms in the factor VII gene and ischemic stroke in young adults. Blood Coagul Fibrinolysis (2010) 0.77
Characteristics of abdominal vein thrombosis in children and adults. Thromb Haemost (2013) 0.77
Estimating the incidence of symptomatic postoperative venous thromboembolism: the importance of perspective. JAMA (2012) 0.77
Hypercoagulability: too many tests, too much conflicting data. Hematology Am Soc Hematol Educ Program (2002) 0.77
Evaluation of a quantitative D-dimer latex immunoassay for acute pulmonary embolism diagnosed by computed tomographic angiography. Mayo Clin Proc (2007) 0.77
Estrogen therapy and thrombotic risk. Pharmacol Ther (2006) 0.76
Should platelet function testing guide antiplatelet therapy for patients with coronary artery stenting or acute coronary syndromes? Clin Chem (2013) 0.76
Incidence of venous thromboembolism after bariatric surgery: a population-based cohort study. Obes Surg (2013) 0.76
Cardiovascular endocrinology: Risk of venous thromboembolism with glucocorticoids. Nat Rev Endocrinol (2013) 0.75